Sveriges mest populära poddar
The Effective Statistician - in association with PSI
The Effective Statistician - in association with PSI

What is the ASAP and what you should know about it

29 min•9 januari 2023
Logga in för att spara

Om avsnittet

Interview with Greg Ball
  • The US FDA has been advocating for aggregate program-level safety evaluations since 1988 when the ISS was introduced (the IND Safety Reporting Final Rule).
  • Aggregate data analysis looks at all available data holistically rather than relying on individual case reports. This allows for a more complete understanding of potential risks associated with a drug or vaccine.
  • In the near future, more companies will adopt a systematic approach to aggregate safety assessment planning and IND safety reporting.
  • This process will develop a better understanding of the safety profile of drugs and ensure that patients' safety is well-thought-of.

Fler avsnitt

Visa alla avsnitt av The Effective Statistician - in association with PSI

Move Beyond Excel with R for Health Technology Assessment

27 min

Turn Data into Decisions by Putting People First

23 min

Better Dose Decisions and a Culture of Statistical Innovation

39 min

Five Lessons for a Meaningful Career in Statistics

42 min

Integrated Evidence Planning That Connects Drug Development to Patient Needs

33 min

How to Make Statistics Click with Schools Outreach and Interactive Data Visualization

28 min

Will AI Replace Statisticians? The Future of Statistics in Pharma

25 min

How to Build an Effective Patient-Reported Outcome Strategy for Clinical Trials

21 min

How the R Consortium Is Transforming Regulatory Submissions and AI in Clinical Trials

18 min

Project Optimus and what you need to know about it

25 min

The Effective Statistician - in association with PSI med Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.